DSpace

DSpace at RU >

Browsing by Author Seynaeve, C.

Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 30 of 30
Full TextIssue DateTitleAuthor(s)
2012Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guidelinede Vos, F.Y.; Laarhoven, H.W.M. van; Laven, J.S.E.; Themmen, A.P.N.; Beex, L.V.A.M., et al
2012Relevant impact of central pathology review on nodal classification in individual breast cancer patientsVestjens, J.H.; Pepels, M.J.; Boer, M. de; Borm, G.F.; Deurzen, C.H. van, et al
2012Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.Kirchhoff, T.; Gaudet, M.M.; Antoniou, A.C.; McGuffog, L.; Humphreys, M.K., et al
2012Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trialSaadatmand, S.; Rutgers, E.J.; Tollenaar, R.A.E.M.; Zonderland, H.M.; Ausems, M.G., et al
2012The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer.Heijer, M. den; Vos, J.; Seynaeve, C.; Vanheusden, K.; Duivenvoorden, H.J., et al
2012Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-studySchilder, C.M.; Seynaeve, C.; Linn, S.C.; Boogerd, W.; Beex, L.V.A.M., et al
2012Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.Jakubowska, A.; Rozkrut, D.; Antoniou, A.; Hamann, U.; Scott, R.J., et al
2012Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study.Heijer, M. den; Seynaeve, C.; Timman, R.; Duivenvoorden, H.J.; Vanheusden, K., et al
2011Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatmentGraan, A.J. de; Teunissen, S.F.; Vos, F.Y. de; Loos, W.J.; Schaik, R.H. van, et al
2011The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patientsSchaik, R.H. van; Kok, M. de; Sweep, F.C.; Vliet, M. van; Fessem, M. van, et al
2011Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Mulligan, A.M.; Couch, F.J.; Barrowdale, D.; Domchek, S.M.; Eccles, D., et al
2010BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.Rijnsburger, A.J.; Obdeijn, I.M.; Kaas, R.; Tilanus-Linthorst, M.M.; Boetes, C., et al
2010Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.Schilder, C.M.; Seynaeve, C.; Beex, L.V.A.M.; Boogerd, W.; Linn, S.C., et al
2010The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy.Schilder, C.M.; Seynaeve, C.; Linn, S.C.; Boogerd, W.; Gundy, C.M., et al
2010Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.Nes, J.G. van; Seynaeve, C.; Maartense, E.; Roumen, R.M.; Jong, R.S. de, et al
2010Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors.Schilder, C.M.; Seynaeve, C.; Linn, S.C.; Boogerd, W.; Beex, L.V.A.M., et al
2009Micrometastases or isolated tumor cells and the outcome of breast cancer.Boer, M. de; Deurzen, C.H. van; Dijck, J.A.A.M. van; Borm, G.F.; Diest, P.J. van, et al
2009No evidence that GATA3 rs570613 SNP modifies breast cancer risk.Johnatty, S.E.; Couch, F.J.; Fredericksen, Z.; Tarrell, R.; Spurdle, A.B., et al
2007The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study.Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
2007Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?Bresser, P.J.; Gool, A.R. van; Seynaeve, C.; Duivenvoorden, H.J.; Niermeijer, M.F., et al
2007Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancerKriege, M.; Brekelmans, C.T.; Peterse, H.; Obdeijn, I.M.; Boetes, C., et al
2007Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
2007The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.Bresser, P.J.; Seynaeve, C.; Gool, A.R. van; Niermeijer, M.F.; Duivenvoorden, H.J., et al
2007A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships.Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
2007Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
2007Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
2006Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer.Kriege, M.; Brekelmans, C.T.; Obdeijn, I.M.; Boetes, C.; Zonderland, H.M., et al
2005Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.Nieboer, P.; Buijs, C.; Rodenhuis, S.; Seynaeve, C.; Beex, L.V.A.M., et al
2005Richtlijn 'Diagnostiek bij wekedelentumoren en behandeling van wekedelensarcomen (herziening)'Geel, A.N. van; Wyrdeman, H.K.; Seynaeve, C.; Hogendoorn, P.C.; Bongaerts, A.H., et al
2004Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.Seynaeve, C.; Verhoog, L.C.; Bosch, L.M. van de; Geel, A.N. van; Menke-Pluymers, M., et al
Showing results 1 to 30 of 30

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback